myeloma

Audio Journal of Oncology in Advance – March 1st, 2008+

4th March 2008

Volume 16 Number 5 (March 1st, 2008) reporting from:
4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
Gastrointestinal Cancers Symposium (January 25-27, 2008, Orlando)
American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)

richard stone Audio Journal of Oncology in Advance   March 1st, 2008
Richard Stone
george canellos Audio Journal of Oncology in Advance   March 1st, 2008
George Canellos

Read More+

“Total Therapy” Possible Cure For Multiple Myeloma?+

26th February 2008

bart barlogie Total Therapy Possible Cure For Multiple Myeloma?
Bart Barlogie

Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
BART BARLOGIE, University of Arkansas, Little Rock
A treatment known as “total therapy” could cure many patients with multiple myeloma, conference-goers have just heard. The targeted

Read More+

Multiple Myeloma: Towards A Chronic Disease With Cure On The Horizon+

25th February 2008

kenneth anderson Multiple Myeloma: Towards A Chronic Disease With Cure On The Horizon
Kenneth Anderson

Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
KENNETH ANDERSON, Dana-Farber Cancer Institute, Boston
Multiple myeloma may soon be considered a chronic disease with cure on the horizon, thanks to an array of novel

Read More+

Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone+

1st February 2008

cora sternberg Hormone Refractory Prostate Cancer: Increased Progression Free Survival With Satraplatin and Prednisone
Cora Sternberg
REFERENCE: Abstract 4010, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
CORA STERNBERG, San Camillo and Forlanini Hospital, Rome
Satraplatin could provide a new option for patients with hormone refractory prostate cancer, by giving

Read More+

Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses+

19th September 2007

georg harter Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses
Georg Härter

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
GEORG HÄRTER, University Hospital, Ulm
For patients with multiple myeloma being treated with the proteasome inhibitor bortezomib, doctor’s should be wary of viral reactivation – and

Read More+

Audio Journal of Oncology in Advance – December 1st, 2006+

1st December 2006

clifford hudis Audio Journal of Oncology in Advance   December 1st, 2006
Clifford Hudis
mark einstein Audio Journal of Oncology in Advance   December 1st, 2006
Mark Einstein
frank greco Audio Journal of Oncology in Advance   December 1st, 2006
Tony Greco
james berenson Audio Journal of Oncology in Advance   December 1st, 2006
James Berenson
edward ambinder Audio Journal of Oncology in Advance   December 1st, 2006
Edward Ambinder

Breast Cancer: HER2 Still a Useful Target After Trastuzumab Resistance

REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006
CLIFFORD HUDIS, Memorial Sloan-Kettering Cancer Center, New York
COMMENT: EDWARD AMBINDER, Mount

Read More+

ASCO Audio Journal of Oncology – June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6+

5th June 2006

robert mayer ASCO Audio Journal of Oncology   June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2 6
Robert Mayer
thierry facon ASCO Audio Journal of Oncology   June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2 6
Thierry Facon
ibrahim yakoub agha ASCO Audio Journal of Oncology   June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2 6
Ibrahim Yakoub-Agha
peter paschka ASCO Audio Journal of Oncology   June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2 6
Peter Paschka

Robert Mayer of the Dana-Farber Cancer Institute in Boston joins Derek Thorne to discuss the major hematologic malignancy news reported at the 2006 ASCO meeting.

- Older patients with multiple myeloma can

Read More+

Audio Journal of Oncology – June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of George Canellos+

3rd June 2006

george canellos Audio Journal of Oncology   June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2 6; in the company of George Canellos
George Canellos
carmela pepe Audio Journal of Oncology   June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2 6; in the company of George Canellos
Carmela Pepe
john goldman Audio Journal of Oncology   June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2 6; in the company of George Canellos
John Goldman
roy herbst Audio Journal of Oncology   June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2 6; in the company of George Canellos
Roy Herbst
sandra horning Audio Journal of Oncology   June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2 6; in the company of George Canellos
Sandra Horning
George Canellos, from the Dana-Farber Cancer Institute in Boston, joins Derek Thorne to talk about the first day’s news at the ASCO annual meeting in Atlanta.

- Elderly patients

Read More+

Targeted Therapies in Multiple Myeloma Treatment Decisions+

21st December 2005

vincent rajkumar Targeted Therapies in Multiple Myeloma Treatment Decisions
Vincent Rajkumar

Vincent Rajkumar, Divison of Hematology, Mayo Clinic
At a section of the hematology meeting talking about newly diagnosed multiple myeloma and the evolving treatments, Vincent Rajkumar discussed new agents such as lenolidamide and thalidomide. Audio Medica asked him …

Read More+